Interim report Q1 2025

Revenio Group Corporation’s January-March 2025 Interim report will be published on Tuesday, April 29, 2024, approximately at 09.00 a.m. (EEST). An audiocast and teleconference call for analysts and investors will be held in English at 3.00 p.m. (EEST) on the same day.

Welcome to Revenio's investor website

Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand. iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for the diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD). iCare Solutions provide digital clinical tools that drive greater efficiency and enhance quality in eye care.



Outlook and guidance

See our guidance

Upcoming events

Latest video

Investor contacts

CFO Robin Pulkkinen robin.pulkkinen(at)revenio.fi